• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies Product Image

Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies

  • ID: 314477
  • January 2006
  • Region: Global
  • 19 pages
  • Centient Consulting, Inc

FEATURED COMPANIES

  • Aastrom
  • Biogen Idec
  • DeltaGen
  • Genta
  • Lexicon Genetics
  • Ribopharma AG
  • MORE

This report examines the three technological advances that are rapidly opening broad new avenues for drug development and therapeutics: monoclonal antibodies, gene manipulation and stem cells. The underlying potential and challenges for each technology from a scientific, market and political perspective are explored. Over 60 public and private companies actively pursuing one or more of these technologies are identified and discussed, providing an in-depth view of the changing landscape of drug discovery and development.

Reasons to Purchase

- Analyze the three technologies changing the face of drug discovery and development
- Identify the companies leveraging these technologies to develop significant new drugs
- Understand the competitive landscape encompassing over 60 companies
- Examine the scientific, market and political factors driving the success or failure of these technologies and companies
- Identify potential collaborative partners and/or investment opportunities

Target Audience

- Business development execs/managers seeking partnership opportunities
- Marketing and senior execs/managers wishing to understand the competitive landscape
- READ MORE >

FEATURED COMPANIES

  • Aastrom
  • Biogen Idec
  • DeltaGen
  • Genta
  • Lexicon Genetics
  • Ribopharma AG
  • MORE

Introduction

Monoclonal Antibodies

Gene Therapy

Gene Silencing
- Knockouts
- Targeting mRNA or Protein
- Ribozymes
- Aptamers
- RNAi

Stem Cells

Sources of Stem Cells

Stem Cell Wars

Aastrom
Abbott
Abgenix
Advanced Cell Technology
Alcon Inc.
Alnylam Pharmaceuticals
Ambion
Amgen
Archemix
Avigen
Biogen Idec
BioInvent
BioRad
Cambridge Antibody Technology
Cancer Research Technology
Ceregene
Chiron
CombiMatrix
Corautus
Crucell
Curis
DanioLabs
DeltaGen
DevGen
Diacrin Inc.
Dyax
Elan
Eli Lilly
Exelixis
Eyetech
Genentech
GenMab
Genta
GenVec
Genzyme
Geron
Gilead
Hybridon
Imclone
Ingenium Pharmaceuticals AG
Invitrogen
Isis Pharmaceuticals
Johnson & Johnson
Lexicon Genetics
Medarex
Medizyme Pharmaceuticals Ltd.
Merck
MorphoSys
Nexstar Pharmaceuticals
Novartis
Pfizer
Phenomix
Protein Design Labs
ReNeuron
Ribopharma AG
Ribozyme Pharmaceuticals
Sangamo
Shire Pharmaceuticals
Sirna Therapeutics
SomaLogic
StemCells
Targeted Therapeutics
Transkaryotic Therapies
ViaCell
Xenogen Biosciences
Xoma

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos